Toll Free : 1-800-489-3075

Global RNA-based Biopharmaceuticals Industry 2017 Market Research Report

Choose License Type
Published by:



Pharmaceuticals & Healthcare

Published On:

July 2017

No of pages:


Report Format:

Electronic (PDF)

In this report, the global RNA-based Biopharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of RNA-based Biopharmaceuticals in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global RNA-based Biopharmaceuticals market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Pfizer
• Roche
• Sanofi-Aventis
• Abbott Laboratories
• Arrowhead Pharmaceuticals
• Benitec Biopharma
• Calimmune Inc
• Dicerna
• Gradalis
• Quark
• RXi
• Senesco
• Silence Therapeutics
• Silenseed
• Tekmira
• Alnylam Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Therapeutics
• Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of RNA-based Biopharmaceuticals for each application, including

• Cancer
• Diabetes
• Tuberculosis
• Cardiovascular Diseases
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.